Literature DB >> 16082226

Blockage of NF-kappaB induces serine 15 phosphorylation of mutant p53 by JNK kinase in prostate cancer cells.

Luiz F Zerbini1, Yihong Wang, Ricardo G Correa, Je-Yoel Cho, Towia A Libermann.   

Abstract

The p53 tumor suppressor gene plays an important role during induction of apoptosis in cancer. In contrast, NF-kappaB prevents apoptosis in response to chemotherapeutic agents and is a critical regulator of cell survival. Despite the riches of information on the regulation of wild-type p53 function by phosphorylation, nothing is known about the modulation of mutant p53 activity by phosphorylation. Here we report that inhibition of NF-kappaB in DU145 prostate cancer cells results in p53 mutant phosphorylation at serine 15 (Ser15), leading to an increase of p53 stability, DNA binding and gain of function. Serine 15-phosphorylation is due to GADD45alpha-dependent induction of JNK kinase, which can be blocked by SP600125, a JNK kinase inhibitor. Furthermore, inhibition of GADD45alpha by small interfering RNA blocks JNK activation and abrogates Ser15 phosphorylation. Together, these results highlight the importance of Ser15 phosphorylation in regulating the oncogenic function of mutant p53 and apoptosis induction in the context of the NF-kappaB/IkappaB signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16082226     DOI: 10.4161/cc.4.9.1966

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  24 in total

1.  Targeting JunD: a potential strategy to counteract hormone-refractory prostate cancer.

Authors:  Devanand Sarkar; Xiang-Yang Wang; Paul B Fisher
Journal:  Cell Cycle       Date:  2011-10-15       Impact factor: 4.534

2.  Transcriptional responses of cancer-related genes in turbot Scophthalmus maximus and mussels Mytilus edulis exposed to heavy fuel oil no. 6 and styrene.

Authors:  Pamela Ruiz; Amaia Orbea; Jeanette M Rotchell; Miren P Cajaraville
Journal:  Ecotoxicology       Date:  2012-02-04       Impact factor: 2.823

3.  JunD-mediated repression of GADD45α and γ regulates escape from cell death in prostate cancer.

Authors:  Luiz Fernando Zerbini; Jaíra Ferreira de Vasconcellos; Akos Czibere; Yihong Wang; Juliano D Paccez; Xuesong Gu; Jin-Rong Zhou; Towia A Libermann
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

4.  Hsp90 inhibitors suppress P53 phosphorylation in LPS - induced endothelial inflammation.

Authors:  Nektarios Barabutis; Mohammad A Uddin; John D Catravas
Journal:  Cytokine       Date:  2018-11-09       Impact factor: 3.861

Review 5.  Mutant TP53 posttranslational modifications: challenges and opportunities.

Authors:  Thuy-Ai Nguyen; Daniel Menendez; Michael A Resnick; Carl W Anderson
Journal:  Hum Mutat       Date:  2014-02-11       Impact factor: 4.878

6.  The DNA binding and accumulation of p53 from breast cancer cell lines and the link with serine 15 phosphorylation.

Authors:  Debolina Ray; Keith R Murphy; Susannah Gal
Journal:  Cancer Biol Ther       Date:  2012-08-01       Impact factor: 4.742

Review 7.  GADD45 proteins: central players in tumorigenesis.

Authors:  R E Tamura; J F de Vasconcellos; D Sarkar; T A Libermann; P B Fisher; L F Zerbini
Journal:  Curr Mol Med       Date:  2012-06       Impact factor: 2.222

8.  Doxorubicin and 5-fluorouracil induced accumulation and transcriptional activity of p53 are independent of the phosphorylation at serine 15 in MCF-7 breast cancer cells.

Authors:  Matthew T Balmer; Ryan D Katz; Si Liao; James S Goodwine; Susannah Gal
Journal:  Cancer Biol Ther       Date:  2014-05-06       Impact factor: 4.742

Review 9.  p53 mutations in cancer.

Authors:  Patricia A J Muller; Karen H Vousden
Journal:  Nat Cell Biol       Date:  2013-01       Impact factor: 28.824

10.  Oligonucleotide microarray analysis of apoptosis induced by 15-methoxypinusolidic acid in microglial BV2 cells.

Authors:  Y Choi; S Y Lim; H S Jeong; K A Koo; S H Sung; Y C Kim
Journal:  Br J Pharmacol       Date:  2009-05-19       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.